Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |